EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cholinergic Degeneration and Cognitive Function in Early GBA1 ‐Related Parkinson's Disease

Sofie Slingerland iD, Sygrid van der Zee iD, Giulia Carli iD, Anne C Slomp iD, Emile d'Angremont iD, Jeffrey M Boertien iD, Teus van Laar iD

Annals of Neurology · 2025-08 · 98 (2) · 398-409

DOI: 10.1002/ana.27248 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Neurology, online erschienen am 16.04.2025. Verfasst von Sofie Slingerland und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Hauptthemen laut MEDLINE: Parkinson Disease, Glucosylceramidase, Cognition, Cognitive Dysfunction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Michael J. Fox Foundation for Parkinson's Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The phenotype of patients with Parkinson's disease carrying GBA 1 variants (GBA‐PD) suggest similarities to symptomatology associated with early cholinergic system degeneration. Therefore, this study aims to investigate the clinical features and the cholinergic innervation pattern in patients with early GBA‐PD versus those without the GBA1 mutation (non‐GBA‐PD).

Methods

A total of 46 GBA‐PD and 104 non‐GBA‐PD subjects were included. Clinical assessments included motor and non‐motor evaluation, as well as a comprehensive neuropsychological examination. Cholinergic system integrity was assessed using 1 8 F‐Fluoroethoxybenzovesamicol ( 18 F‐FEOBV) positron emission tomography (PET) to investigate the differences between GBA‐PD and non‐GBA‐PD. Given the higher prevalence of females in GBA‐PD, analyses were repeated when stratified by sex. Additionally, we examined the association between cognitive domains and whole‐brain cholinergic binding in both groups. Exploratory analyses examined clinical and 18 F‐FEOBV binding differences among GBA1 variants.

Results

GBA‐PD patients exhibited a higher burden of non‐motor symptoms and lower cognitive performance on executive functions and attention. We observed a more pronounced cholinergic denervation in GBA‐PD, compared to non‐GBA‐PD, primarily in the anterior, central, and limbic regions. However, the distribution of cholinergic loss and its association with attention and executive dysfunction was comparable between GBA‐PD and non‐GBA‐PD. In addition, the clinical presentation and cholinergic binding differed significantly between sexes.

Interpretation

These results suggest an important role of early cholinergic denervation in GBA‐PD patients, which is related to more severe cognitive dysfunction. ANN NEUROL 2025;98:398–409

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseGlucosylceramidaseCognitionCognitive DysfunctionCholinergic NeuronsHumansMaleFemaleMiddle AgedAgedPositron-Emission TomographyBrainNeuropsychological TestsMutation

Substanzen

GlucosylceramidaseGBA protein, human

Autor:innen und Institutionen

  • Department of Neurology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Department of Neurology, Division of Clinical Neuropsychology, University of Groningen, University Medical Center, Groningen, The Netherlands.
  • Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Department of Neurology, University of Michigan, Ann Arbor, MI.
  • Department of Biomedical Sciences, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

ORCID-Profile: Sofie Slingerland, Sygrid van der Zee, Giulia Carli, Anne C Slomp, Emile d'Angremont, Jeffrey M Boertien, Teus van Laar

Förderung

  • Michael J. Fox Foundation for Parkinson's Research

Zitieren

APA

Slingerland, S., van der Zee, S., Carli, G., Slomp, A. C., d'Angremont, E., Boertien, J. M., & van Laar, T. (2025). Cholinergic Degeneration and Cognitive Function in Early GBA1 ‐Related Parkinson's Disease. Annals of Neurology, 98(2), 398-409. https://doi.org/10.1002/ana.27248

Vancouver

Slingerland S, van der Zee S, Carli G, Slomp AC, d'Angremont E, Boertien JM, et al. Cholinergic Degeneration and Cognitive Function in Early GBA1 ‐Related Parkinson's Disease. Annals of Neurology. 2025;98(2):398-409. doi:10.1002/ana.27248

BibTeX
@article{Slingerland2025,
  author = {Slingerland, Sofie and van der Zee, Sygrid and Carli, Giulia and Slomp, Anne C and d'Angremont, Emile and Boertien, Jeffrey M and van Laar, Teus},
  title = {Cholinergic Degeneration and Cognitive Function in Early GBA1 ‐Related Parkinson's Disease},
  journal = {Annals of Neurology},
  year = {2025},
  volume = {98},
  number = {2},
  pages = {398--409},
  doi = {10.1002/ana.27248}
}
Kostenlos starten →